The authors' response: Propofol in COVID 19: From basic science to clinical impact

Am J Emerg Med. 2021 Jul:45:528. doi: 10.1016/j.ajem.2020.07.006. Epub 2020 Jul 9.

Authors

Mitsuhito Soh¹, Toru Hifumi², Shutaro Isokawa¹, Masato Shimizu¹, Norio Otani¹, Shinichi Ishimatsu¹

Affiliations

¹ Emergency and Critical Care Medicine, St. Luke's International Hospital, Tokyo, Japan.
² Emergency and Critical Care Medicine, St. Luke's International Hospital, Tokyo, Japan. Electronic address: hifumitoru@gmail.com.

No abstract available

Keywords: COVID-19; Neuroleptic malignant syndrome; Propofol.

Publication types

Letter
Comment

MeSH terms

COVID-19*
Humans
Hypnotics and Sedatives
Neuroleptic Malignant Syndrome*
Propofol*
SARS-CoV-2

Substances

Hypnotics and Sedatives
Propofol